| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Psychotherapy | 84 | 2023 | 1643 | 12.480 |
Why?
|
| Anxiety | 45 | 2023 | 4296 | 7.030 |
Why?
|
| Depression | 57 | 2023 | 7766 | 6.500 |
Why?
|
| Anxiety Disorders | 50 | 2023 | 2690 | 5.390 |
Why?
|
| Depressive Disorder | 33 | 2021 | 3748 | 3.760 |
Why?
|
| Conduct Disorder | 11 | 2019 | 241 | 3.050 |
Why?
|
| Child Behavior Disorders | 34 | 2023 | 807 | 2.870 |
Why?
|
| Mental Disorders | 49 | 2022 | 6600 | 2.660 |
Why?
|
| Mental Health | 20 | 2024 | 3014 | 2.580 |
Why?
|
| Community Mental Health Services | 18 | 2020 | 386 | 2.510 |
Why?
|
| Evidence-Based Practice | 13 | 2020 | 501 | 2.360 |
Why?
|
| Adolescent | 213 | 2024 | 85784 | 2.340 |
Why?
|
| Internal-External Control | 26 | 2017 | 363 | 2.240 |
Why?
|
| Child Behavior | 10 | 2019 | 839 | 2.120 |
Why?
|
| Psychometrics | 28 | 2022 | 3002 | 2.030 |
Why?
|
| Kenya | 20 | 2024 | 685 | 1.930 |
Why?
|
| Cross-Cultural Comparison | 24 | 2021 | 651 | 1.910 |
Why?
|
| Parents | 21 | 2023 | 3405 | 1.800 |
Why?
|
| Parent-Child Relations | 16 | 2018 | 747 | 1.770 |
Why?
|
| Child | 194 | 2023 | 77708 | 1.760 |
Why?
|
| Behavioral Symptoms | 3 | 2021 | 175 | 1.730 |
Why?
|
| Child of Impaired Parents | 4 | 2019 | 455 | 1.450 |
Why?
|
| Mental Health Services | 14 | 2022 | 1643 | 1.430 |
Why?
|
| Psychotherapy, Brief | 4 | 2020 | 114 | 1.370 |
Why?
|
| Adolescent Behavior | 9 | 2017 | 1151 | 1.340 |
Why?
|
| Models, Psychological | 10 | 2016 | 811 | 1.290 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 6 | 2020 | 304 | 1.230 |
Why?
|
| Motivation | 8 | 2020 | 1971 | 1.120 |
Why?
|
| Professional-Patient Relations | 5 | 2019 | 737 | 1.110 |
Why?
|
| Referral and Consultation | 14 | 2020 | 3529 | 1.110 |
Why?
|
| Adolescent Psychiatry | 3 | 2020 | 148 | 1.090 |
Why?
|
| Estrogens, Catechol | 19 | 2000 | 25 | 1.050 |
Why?
|
| Personality | 4 | 2017 | 552 | 1.020 |
Why?
|
| Emotions | 6 | 2023 | 2658 | 1.000 |
Why?
|
| Irritable Mood | 3 | 2022 | 183 | 0.990 |
Why?
|
| Child Psychiatry | 4 | 2015 | 220 | 0.980 |
Why?
|
| Parenting | 8 | 2016 | 679 | 0.970 |
Why?
|
| Humans | 311 | 2024 | 744376 | 0.960 |
Why?
|
| Randomized Controlled Trials as Topic | 18 | 2023 | 9957 | 0.930 |
Why?
|
| Family Relations | 2 | 2016 | 321 | 0.870 |
Why?
|
| Psychotherapy, Group | 3 | 2021 | 406 | 0.830 |
Why?
|
| Male | 217 | 2024 | 350118 | 0.820 |
Why?
|
| Female | 234 | 2024 | 380200 | 0.820 |
Why?
|
| Health Personnel | 6 | 2020 | 3219 | 0.810 |
Why?
|
| Adolescent Health Services | 5 | 2015 | 215 | 0.800 |
Why?
|
| Adaptation, Psychological | 11 | 2017 | 2575 | 0.800 |
Why?
|
| Caregivers | 5 | 2022 | 2095 | 0.800 |
Why?
|
| Antisocial Personality Disorder | 3 | 2014 | 228 | 0.780 |
Why?
|
| Evidence-Based Medicine | 12 | 2020 | 3610 | 0.730 |
Why?
|
| Allied Health Personnel | 1 | 2021 | 162 | 0.710 |
Why?
|
| Fluoxetine | 3 | 2021 | 749 | 0.700 |
Why?
|
| Feminism | 1 | 2019 | 6 | 0.700 |
Why?
|
| Family Therapy | 3 | 2016 | 207 | 0.690 |
Why?
|
| Peer Group | 2 | 2019 | 635 | 0.660 |
Why?
|
| Self Disclosure | 2 | 2019 | 251 | 0.660 |
Why?
|
| Treatment Outcome | 50 | 2023 | 63115 | 0.660 |
Why?
|
| Health Services Research | 6 | 2020 | 1836 | 0.660 |
Why?
|
| Personality Assessment | 13 | 2009 | 647 | 0.650 |
Why?
|
| Cytochrome P-450 CYP1A1 | 9 | 1992 | 91 | 0.640 |
Why?
|
| Psychological Theory | 4 | 2016 | 168 | 0.630 |
Why?
|
| Steroid Hydroxylases | 9 | 1992 | 96 | 0.590 |
Why?
|
| Psychiatric Status Rating Scales | 11 | 2016 | 6038 | 0.580 |
Why?
|
| Research Design | 12 | 2022 | 5986 | 0.580 |
Why?
|
| Behavior Therapy | 8 | 2021 | 865 | 0.560 |
Why?
|
| Depression, Postpartum | 1 | 2021 | 340 | 0.560 |
Why?
|
| Mental Competency | 1 | 2017 | 176 | 0.560 |
Why?
|
| Interpersonal Relations | 3 | 2019 | 1425 | 0.540 |
Why?
|
| Community Mental Health Centers | 7 | 2013 | 102 | 0.540 |
Why?
|
| Social Environment | 6 | 2022 | 1023 | 0.540 |
Why?
|
| Estradiol | 30 | 1998 | 2020 | 0.530 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 3 | 2021 | 3658 | 0.530 |
Why?
|
| Reproducibility of Results | 25 | 2022 | 19905 | 0.520 |
Why?
|
| Depressive Disorder, Major | 6 | 2021 | 4644 | 0.520 |
Why?
|
| Manuals as Topic | 3 | 2011 | 98 | 0.510 |
Why?
|
| Professional Practice | 1 | 2017 | 326 | 0.490 |
Why?
|
| Affective Symptoms | 6 | 1997 | 407 | 0.470 |
Why?
|
| Self Report | 5 | 2019 | 3557 | 0.470 |
Why?
|
| Social Stigma | 2 | 2022 | 701 | 0.460 |
Why?
|
| Interview, Psychological | 6 | 2015 | 812 | 0.460 |
Why?
|
| Stress Disorders, Post-Traumatic | 5 | 2022 | 4266 | 0.440 |
Why?
|
| Developing Countries | 3 | 2022 | 2815 | 0.430 |
Why?
|
| Autistic Disorder | 1 | 2021 | 1185 | 0.410 |
Why?
|
| Patient Dropouts | 5 | 2017 | 421 | 0.410 |
Why?
|
| Catechol O-Methyltransferase | 7 | 2000 | 245 | 0.400 |
Why?
|
| Thailand | 14 | 2009 | 296 | 0.400 |
Why?
|
| Dominance, Cerebral | 5 | 1999 | 635 | 0.400 |
Why?
|
| Research | 5 | 2017 | 1999 | 0.370 |
Why?
|
| Social Control, Informal | 1 | 2010 | 46 | 0.370 |
Why?
|
| Aggression | 6 | 2003 | 753 | 0.360 |
Why?
|
| Factor Analysis, Statistical | 6 | 2015 | 977 | 0.360 |
Why?
|
| School Health Services | 3 | 2020 | 375 | 0.360 |
Why?
|
| Mother-Child Relations | 4 | 2021 | 481 | 0.350 |
Why?
|
| Cost-Benefit Analysis | 3 | 2023 | 5390 | 0.350 |
Why?
|
| Luteinizing Hormone | 15 | 1989 | 869 | 0.350 |
Why?
|
| Child Health Services | 6 | 2020 | 667 | 0.350 |
Why?
|
| Decision Trees | 1 | 2011 | 506 | 0.350 |
Why?
|
| Stress, Psychological | 8 | 2016 | 4244 | 0.340 |
Why?
|
| Ego | 2 | 2000 | 96 | 0.340 |
Why?
|
| Tretinoin | 2 | 2002 | 517 | 0.340 |
Why?
|
| Schools | 4 | 2022 | 1433 | 0.340 |
Why?
|
| Breast | 4 | 2003 | 1970 | 0.330 |
Why?
|
| Family Characteristics | 1 | 2014 | 1000 | 0.330 |
Why?
|
| Meta-Analysis as Topic | 5 | 2007 | 1343 | 0.320 |
Why?
|
| Hypothalamus | 15 | 1986 | 1063 | 0.320 |
Why?
|
| NADP | 11 | 1998 | 226 | 0.320 |
Why?
|
| Ambulatory Care | 6 | 2016 | 2708 | 0.310 |
Why?
|
| Adult | 67 | 2023 | 214056 | 0.310 |
Why?
|
| Psychological Tests | 5 | 2004 | 651 | 0.310 |
Why?
|
| Clinical Competence | 3 | 2021 | 4687 | 0.300 |
Why?
|
| Juvenile Delinquency | 5 | 2010 | 125 | 0.290 |
Why?
|
| Artificial Intelligence | 1 | 2020 | 2213 | 0.290 |
Why?
|
| Child Development | 12 | 2000 | 2223 | 0.290 |
Why?
|
| Estrogens | 7 | 2000 | 1566 | 0.290 |
Why?
|
| Attitude | 7 | 2018 | 776 | 0.290 |
Why?
|
| Microsomes | 6 | 1998 | 257 | 0.280 |
Why?
|
| Decision Making | 3 | 2022 | 3888 | 0.280 |
Why?
|
| Ambulatory Care Facilities | 2 | 2023 | 934 | 0.280 |
Why?
|
| Telemedicine | 2 | 2023 | 2872 | 0.280 |
Why?
|
| Wounds and Injuries | 1 | 2019 | 2400 | 0.270 |
Why?
|
| Child Abuse | 2 | 2006 | 1030 | 0.270 |
Why?
|
| Cytochrome P-450 Enzyme System | 7 | 1998 | 419 | 0.270 |
Why?
|
| Chronic Disease | 2 | 2020 | 9145 | 0.270 |
Why?
|
| Health Services Needs and Demand | 3 | 2011 | 1410 | 0.270 |
Why?
|
| Culture | 2 | 2000 | 633 | 0.270 |
Why?
|
| Clinical Protocols | 6 | 2018 | 1462 | 0.270 |
Why?
|
| Income | 1 | 2015 | 1913 | 0.270 |
Why?
|
| Glucosephosphate Dehydrogenase | 7 | 1992 | 207 | 0.270 |
Why?
|
| Mood Disorders | 2 | 2020 | 1106 | 0.270 |
Why?
|
| Residential Treatment | 1 | 2006 | 111 | 0.270 |
Why?
|
| Aromatase | 5 | 1996 | 147 | 0.260 |
Why?
|
| Needs Assessment | 1 | 2011 | 1146 | 0.260 |
Why?
|
| Alcohol Dehydrogenase | 2 | 2003 | 119 | 0.260 |
Why?
|
| Attitude to Health | 4 | 2017 | 2052 | 0.250 |
Why?
|
| Hydroxyestrones | 3 | 2002 | 17 | 0.250 |
Why?
|
| Therapy, Computer-Assisted | 2 | 2017 | 274 | 0.250 |
Why?
|
| Child, Preschool | 26 | 2021 | 41005 | 0.250 |
Why?
|
| Glucuronosyltransferase | 2 | 2002 | 128 | 0.240 |
Why?
|
| 3-Hydroxysteroid Dehydrogenases | 6 | 1990 | 34 | 0.240 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2004 | 32 | 0.240 |
Why?
|
| Testosterone | 22 | 1994 | 2419 | 0.240 |
Why?
|
| Rheumatic Fever | 1 | 2004 | 71 | 0.230 |
Why?
|
| Ovary | 17 | 1987 | 981 | 0.230 |
Why?
|
| Functional Laterality | 4 | 2001 | 2290 | 0.230 |
Why?
|
| Cultural Characteristics | 2 | 2006 | 262 | 0.230 |
Why?
|
| Object Attachment | 3 | 2001 | 313 | 0.230 |
Why?
|
| Social Adjustment | 5 | 2000 | 631 | 0.230 |
Why?
|
| Expressed Emotion | 1 | 2004 | 92 | 0.230 |
Why?
|
| Guideline Adherence | 4 | 2021 | 2265 | 0.230 |
Why?
|
| Oxidoreductases | 7 | 1984 | 424 | 0.230 |
Why?
|
| Benchmarking | 2 | 2017 | 1042 | 0.230 |
Why?
|
| Violence | 3 | 2017 | 909 | 0.220 |
Why?
|
| Leydig Cells | 7 | 1990 | 56 | 0.220 |
Why?
|
| Practice Guidelines as Topic | 3 | 2017 | 7281 | 0.220 |
Why?
|
| Loneliness | 2 | 2022 | 185 | 0.220 |
Why?
|
| Combined Modality Therapy | 5 | 2020 | 8642 | 0.220 |
Why?
|
| Vision, Monocular | 2 | 1994 | 78 | 0.210 |
Why?
|
| Pressoreceptors | 2 | 2002 | 100 | 0.210 |
Why?
|
| Patient Compliance | 3 | 2003 | 2685 | 0.210 |
Why?
|
| Follow-Up Studies | 15 | 2022 | 39052 | 0.210 |
Why?
|
| Biomedical Research | 2 | 2015 | 3309 | 0.210 |
Why?
|
| Attitude of Health Personnel | 3 | 2013 | 3842 | 0.210 |
Why?
|
| Family | 7 | 2014 | 3147 | 0.210 |
Why?
|
| Visceral Afferents | 1 | 2001 | 9 | 0.210 |
Why?
|
| Carotid Sinus | 1 | 2001 | 45 | 0.210 |
Why?
|
| Visual Perception | 4 | 1994 | 1420 | 0.210 |
Why?
|
| Sex Factors | 13 | 2015 | 10400 | 0.200 |
Why?
|
| Personality Inventory | 5 | 2010 | 1030 | 0.200 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 5 | 2016 | 1953 | 0.200 |
Why?
|
| Isoantigens | 1 | 2004 | 567 | 0.200 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2002 | 170 | 0.200 |
Why?
|
| Antigens, CD19 | 1 | 2004 | 380 | 0.200 |
Why?
|
| Age Factors | 15 | 2015 | 18373 | 0.190 |
Why?
|
| Personality Development | 7 | 2001 | 245 | 0.190 |
Why?
|
| Tourette Syndrome | 1 | 2004 | 379 | 0.190 |
Why?
|
| Verbal Behavior | 1 | 2002 | 339 | 0.190 |
Why?
|
| Ethnopsychology | 1 | 2000 | 22 | 0.190 |
Why?
|
| Single-Blind Method | 2 | 2021 | 1591 | 0.190 |
Why?
|
| Delivery of Health Care | 4 | 2022 | 5321 | 0.190 |
Why?
|
| Baroreflex | 1 | 2001 | 146 | 0.190 |
Why?
|
| Rats | 60 | 2000 | 24252 | 0.190 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2018 | 3020 | 0.180 |
Why?
|
| RNA, Neoplasm | 1 | 2003 | 769 | 0.180 |
Why?
|
| Pituitary Gland, Anterior | 5 | 1989 | 177 | 0.180 |
Why?
|
| Eye Movements | 3 | 1993 | 507 | 0.180 |
Why?
|
| Antidepressive Agents | 5 | 2021 | 2838 | 0.180 |
Why?
|
| Heart Rate | 5 | 1994 | 4091 | 0.180 |
Why?
|
| Young Adult | 11 | 2023 | 56434 | 0.180 |
Why?
|
| Maternal Behavior | 1 | 2002 | 311 | 0.180 |
Why?
|
| Happiness | 1 | 2021 | 170 | 0.180 |
Why?
|
| Tolmetin | 1 | 1999 | 23 | 0.180 |
Why?
|
| Hawaii | 4 | 2013 | 105 | 0.180 |
Why?
|
| Psychology, Clinical | 2 | 1998 | 42 | 0.180 |
Why?
|
| Pseudophakia | 1 | 1999 | 62 | 0.170 |
Why?
|
| Endometrium | 1 | 2002 | 424 | 0.170 |
Why?
|
| Estrone | 11 | 1996 | 240 | 0.170 |
Why?
|
| Microsomes, Liver | 6 | 1994 | 173 | 0.170 |
Why?
|
| Stress, Physiological | 6 | 1990 | 1403 | 0.170 |
Why?
|
| Estradiol Congeners | 1 | 1998 | 28 | 0.170 |
Why?
|
| Thioacetamide | 2 | 1997 | 15 | 0.160 |
Why?
|
| Dihydrotestosterone | 7 | 1979 | 190 | 0.160 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2000 | 338 | 0.160 |
Why?
|
| Vagina | 1 | 2004 | 825 | 0.160 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 2 | 1992 | 257 | 0.160 |
Why?
|
| Fetal Tissue Transplantation | 1 | 1999 | 139 | 0.160 |
Why?
|
| Pigment Epithelium of Eye | 1 | 1999 | 220 | 0.160 |
Why?
|
| Observer Variation | 5 | 2015 | 2593 | 0.160 |
Why?
|
| RNA, Messenger | 6 | 2004 | 13035 | 0.160 |
Why?
|
| Comorbidity | 3 | 2023 | 10388 | 0.160 |
Why?
|
| Testis | 8 | 1990 | 804 | 0.160 |
Why?
|
| Ethinyl Estradiol | 1 | 1998 | 116 | 0.150 |
Why?
|
| Mothers | 2 | 2013 | 2165 | 0.150 |
Why?
|
| Macula Lutea | 1 | 1999 | 151 | 0.150 |
Why?
|
| Norway | 1 | 2019 | 448 | 0.150 |
Why?
|
| Camping | 1 | 1997 | 13 | 0.150 |
Why?
|
| Cooperative Behavior | 2 | 2016 | 1504 | 0.150 |
Why?
|
| Speech | 1 | 2002 | 541 | 0.150 |
Why?
|
| Progesterone | 8 | 1987 | 775 | 0.150 |
Why?
|
| Anxiety, Separation | 1 | 1997 | 86 | 0.150 |
Why?
|
| Open Reading Frames | 1 | 2000 | 811 | 0.150 |
Why?
|
| Rats, Inbred Strains | 15 | 1990 | 2186 | 0.150 |
Why?
|
| Prostatic Neoplasms | 1 | 2020 | 11126 | 0.150 |
Why?
|
| Affect | 2 | 2002 | 1475 | 0.140 |
Why?
|
| Defense Mechanisms | 2 | 2016 | 178 | 0.140 |
Why?
|
| Severity of Illness Index | 8 | 2018 | 15535 | 0.140 |
Why?
|
| Cell Transplantation | 1 | 1999 | 477 | 0.140 |
Why?
|
| Computer Graphics | 1 | 1999 | 361 | 0.140 |
Why?
|
| Ethanol | 1 | 2003 | 1342 | 0.140 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2019 | 503 | 0.140 |
Why?
|
| Aldehydes | 1 | 1997 | 167 | 0.140 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 1992 | 494 | 0.140 |
Why?
|
| Attention | 7 | 1999 | 2397 | 0.140 |
Why?
|
| Evoked Potentials, Visual | 1 | 1999 | 427 | 0.140 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2003 | 1100 | 0.140 |
Why?
|
| Sequence Deletion | 1 | 2000 | 1526 | 0.140 |
Why?
|
| Self Concept | 3 | 1999 | 1025 | 0.140 |
Why?
|
| Androstanes | 6 | 1979 | 21 | 0.140 |
Why?
|
| Therapeutics | 2 | 1995 | 116 | 0.130 |
Why?
|
| HLA-DR1 Antigen | 1 | 1995 | 12 | 0.130 |
Why?
|
| HLA-DR4 Antigen | 1 | 1995 | 29 | 0.130 |
Why?
|
| Sampling Studies | 3 | 2005 | 623 | 0.130 |
Why?
|
| Students | 5 | 2024 | 1651 | 0.130 |
Why?
|
| Uveomeningoencephalitic Syndrome | 1 | 1995 | 19 | 0.130 |
Why?
|
| Breast Neoplasms | 7 | 2003 | 20823 | 0.130 |
Why?
|
| Social Values | 3 | 2006 | 224 | 0.130 |
Why?
|
| Macular Edema | 1 | 1999 | 359 | 0.130 |
Why?
|
| Diffusion of Innovation | 2 | 2012 | 725 | 0.130 |
Why?
|
| Suicidal Ideation | 2 | 2022 | 1246 | 0.130 |
Why?
|
| Cataract Extraction | 1 | 1999 | 481 | 0.130 |
Why?
|
| Kinetics | 18 | 1992 | 6476 | 0.130 |
Why?
|
| Universities | 1 | 2020 | 956 | 0.130 |
Why?
|
| Checklist | 2 | 2013 | 833 | 0.130 |
Why?
|
| Diagnosis | 1 | 1995 | 154 | 0.120 |
Why?
|
| Health Care Surveys | 2 | 2012 | 2453 | 0.120 |
Why?
|
| Tomography, Emission-Computed | 3 | 2002 | 1144 | 0.120 |
Why?
|
| Sexual Behavior, Animal | 3 | 1984 | 113 | 0.120 |
Why?
|
| Galvanic Skin Response | 1 | 2016 | 349 | 0.120 |
Why?
|
| Habits | 1 | 2015 | 139 | 0.120 |
Why?
|
| Hemiplegia | 1 | 1995 | 135 | 0.120 |
Why?
|
| Child Rearing | 3 | 1989 | 74 | 0.120 |
Why?
|
| Analysis of Variance | 7 | 2011 | 6366 | 0.120 |
Why?
|
| Fetus | 7 | 1989 | 1880 | 0.120 |
Why?
|
| Commitment of Mentally Ill | 2 | 1990 | 94 | 0.120 |
Why?
|
| Cross-Sectional Studies | 9 | 2024 | 25041 | 0.120 |
Why?
|
| Psychotropic Drugs | 1 | 1999 | 894 | 0.110 |
Why?
|
| Sick Role | 1 | 1994 | 237 | 0.110 |
Why?
|
| Middle Aged | 21 | 2020 | 213388 | 0.110 |
Why?
|
| Sertraline | 1 | 2014 | 206 | 0.110 |
Why?
|
| Suicide | 1 | 2024 | 1474 | 0.110 |
Why?
|
| Patient Satisfaction | 3 | 2020 | 3395 | 0.110 |
Why?
|
| Health Promotion | 1 | 2005 | 2205 | 0.110 |
Why?
|
| Clinical Trials as Topic | 3 | 2004 | 7914 | 0.110 |
Why?
|
| Multilevel Analysis | 1 | 2013 | 142 | 0.110 |
Why?
|
| Urban Population | 2 | 2011 | 2022 | 0.110 |
Why?
|
| Tissue Distribution | 6 | 2002 | 2327 | 0.110 |
Why?
|
| Education, Continuing | 1 | 2013 | 112 | 0.110 |
Why?
|
| Oxidation-Reduction | 3 | 1997 | 2184 | 0.110 |
Why?
|
| Los Angeles | 3 | 2003 | 238 | 0.110 |
Why?
|
| Taste | 2 | 2004 | 176 | 0.110 |
Why?
|
| Estrus | 8 | 1984 | 81 | 0.110 |
Why?
|
| Professional Competence | 2 | 2012 | 447 | 0.110 |
Why?
|
| Public Health | 2 | 2023 | 2602 | 0.110 |
Why?
|
| Electroencephalography | 5 | 2004 | 6150 | 0.110 |
Why?
|
| Animals | 84 | 2021 | 168770 | 0.110 |
Why?
|
| Prognosis | 4 | 2020 | 29060 | 0.110 |
Why?
|
| Endometrial Neoplasms | 1 | 2002 | 1351 | 0.110 |
Why?
|
| Teaching | 4 | 1991 | 1174 | 0.110 |
Why?
|
| Subfornical Organ | 1 | 1992 | 9 | 0.110 |
Why?
|
| Arousal | 3 | 1999 | 1164 | 0.110 |
Why?
|
| Risk Factors | 11 | 2022 | 72295 | 0.110 |
Why?
|
| NADPH Dehydrogenase | 1 | 1992 | 45 | 0.110 |
Why?
|
| Individuality | 2 | 1993 | 307 | 0.100 |
Why?
|
| Kidney | 5 | 1998 | 7184 | 0.100 |
Why?
|
| Social Work | 2 | 2013 | 162 | 0.100 |
Why?
|
| Theft | 1 | 1991 | 19 | 0.100 |
Why?
|
| User-Computer Interface | 1 | 1999 | 1431 | 0.100 |
Why?
|
| Forms and Records Control | 1 | 2012 | 160 | 0.100 |
Why?
|
| Fear | 1 | 2020 | 1440 | 0.100 |
Why?
|
| Immunohistochemistry | 7 | 2004 | 11366 | 0.100 |
Why?
|
| Granulosa Cells | 3 | 1986 | 121 | 0.100 |
Why?
|
| RNA-Binding Proteins | 1 | 2000 | 1903 | 0.100 |
Why?
|
| Enzyme Induction | 3 | 2003 | 475 | 0.100 |
Why?
|
| Macular Degeneration | 1 | 1999 | 980 | 0.100 |
Why?
|
| Tyrosine 3-Monooxygenase | 3 | 1982 | 375 | 0.100 |
Why?
|
| Cell Nucleus | 1 | 2000 | 2969 | 0.100 |
Why?
|
| Clinical Coding | 1 | 2012 | 171 | 0.100 |
Why?
|
| Prefrontal Cortex | 1 | 2001 | 2147 | 0.100 |
Why?
|
| Developmental Disabilities | 1 | 1999 | 1456 | 0.100 |
Why?
|
| Outpatients | 1 | 2019 | 1487 | 0.100 |
Why?
|
| Faculty | 1 | 2014 | 386 | 0.090 |
Why?
|
| Neoplasm Proteins | 1 | 2003 | 3706 | 0.090 |
Why?
|
| B-Lymphocytes | 1 | 2004 | 4666 | 0.090 |
Why?
|
| Personal Satisfaction | 1 | 2015 | 643 | 0.090 |
Why?
|
| Concept Formation | 4 | 1995 | 158 | 0.090 |
Why?
|
| United States | 24 | 2017 | 69869 | 0.090 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2014 | 2428 | 0.090 |
Why?
|
| Qualitative Research | 1 | 2019 | 2682 | 0.090 |
Why?
|
| Tritium | 11 | 1986 | 745 | 0.090 |
Why?
|
| Kidney Tubules, Proximal | 2 | 1998 | 416 | 0.090 |
Why?
|
| Neurasthenia | 1 | 2009 | 17 | 0.090 |
Why?
|
| Awareness | 1 | 1994 | 640 | 0.090 |
Why?
|
| Cerebral Infarction | 1 | 1995 | 1011 | 0.090 |
Why?
|
| Community Networks | 1 | 2011 | 203 | 0.090 |
Why?
|
| Japan | 4 | 2001 | 1360 | 0.090 |
Why?
|
| Sex Differentiation | 4 | 1984 | 73 | 0.090 |
Why?
|
| Mental Processes | 1 | 1991 | 249 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1999 | 2282 | 0.090 |
Why?
|
| Mesocricetus | 5 | 1998 | 252 | 0.090 |
Why?
|
| Elimination Disorders | 1 | 2008 | 1 | 0.080 |
Why?
|
| Twins | 1 | 1991 | 339 | 0.080 |
Why?
|
| Anthropology, Cultural | 2 | 2008 | 99 | 0.080 |
Why?
|
| Choroid Plexus | 1 | 1992 | 231 | 0.080 |
Why?
|
| Polymorphism, Genetic | 1 | 2000 | 4328 | 0.080 |
Why?
|
| Gene Expression | 1 | 2002 | 7798 | 0.080 |
Why?
|
| Gonadotropin-Releasing Hormone | 3 | 1982 | 1206 | 0.080 |
Why?
|
| Fixation, Ocular | 1 | 1990 | 251 | 0.080 |
Why?
|
| Androstane-3,17-diol | 2 | 1979 | 19 | 0.080 |
Why?
|
| Ovulation | 6 | 1986 | 189 | 0.080 |
Why?
|
| Thalamus | 1 | 1995 | 1023 | 0.080 |
Why?
|
| Brain | 10 | 2002 | 26386 | 0.080 |
Why?
|
| Gender Identity | 4 | 2020 | 687 | 0.080 |
Why?
|
| Immunoblotting | 3 | 2002 | 1683 | 0.080 |
Why?
|
| Syndrome | 2 | 2006 | 3252 | 0.080 |
Why?
|
| Perception | 2 | 2022 | 1198 | 0.080 |
Why?
|
| Poverty | 1 | 2020 | 2660 | 0.080 |
Why?
|
| New England | 1 | 2011 | 1022 | 0.080 |
Why?
|
| Organizational Culture | 1 | 2012 | 510 | 0.080 |
Why?
|
| Cognition | 3 | 2020 | 6770 | 0.080 |
Why?
|
| Quality Assurance, Health Care | 1 | 2019 | 2212 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2000 | 5096 | 0.080 |
Why?
|
| Fetal Blood | 4 | 1989 | 1318 | 0.080 |
Why?
|
| Fundus Oculi | 2 | 1999 | 473 | 0.080 |
Why?
|
| NAD | 6 | 2003 | 590 | 0.080 |
Why?
|
| Psychotic Disorders | 1 | 2023 | 3046 | 0.080 |
Why?
|
| Pituitary Gland | 6 | 1981 | 665 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2003 | 8432 | 0.080 |
Why?
|
| Respiratory Physiological Phenomena | 2 | 2001 | 188 | 0.080 |
Why?
|
| New Zealand | 2 | 2020 | 355 | 0.080 |
Why?
|
| Cluster Analysis | 1 | 2014 | 2715 | 0.080 |
Why?
|
| Feasibility Studies | 3 | 2015 | 5077 | 0.070 |
Why?
|
| Nitric Oxide Synthase | 4 | 1999 | 915 | 0.070 |
Why?
|
| Hydroxylation | 3 | 1998 | 141 | 0.070 |
Why?
|
| Substance-Related Disorders | 2 | 2022 | 4257 | 0.070 |
Why?
|
| Tissue Extracts | 3 | 1977 | 135 | 0.070 |
Why?
|
| Molecular Sequence Data | 6 | 2004 | 18111 | 0.070 |
Why?
|
| Glutathione Transferase | 2 | 2000 | 595 | 0.070 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2004 | 280 | 0.070 |
Why?
|
| Somatoform Disorders | 1 | 2009 | 423 | 0.070 |
Why?
|
| Amino Acid Sequence | 4 | 2004 | 13814 | 0.070 |
Why?
|
| Follicle Stimulating Hormone | 6 | 1981 | 744 | 0.070 |
Why?
|
| Prevalence | 4 | 2022 | 15221 | 0.070 |
Why?
|
| Quality of Health Care | 2 | 2019 | 4369 | 0.070 |
Why?
|
| Predictive Value of Tests | 3 | 2018 | 15078 | 0.070 |
Why?
|
| Liver | 4 | 2000 | 7475 | 0.070 |
Why?
|
| Kidney Tubules, Distal | 1 | 1985 | 46 | 0.070 |
Why?
|
| Social Identification | 1 | 2006 | 103 | 0.070 |
Why?
|
| Diagnosis, Differential | 2 | 2013 | 12961 | 0.070 |
Why?
|
| Histocytochemistry | 9 | 1985 | 719 | 0.070 |
Why?
|
| Organizational Innovation | 1 | 2009 | 559 | 0.070 |
Why?
|
| Achievement | 3 | 1982 | 291 | 0.070 |
Why?
|
| Cricetinae | 5 | 1998 | 2475 | 0.070 |
Why?
|
| Workload | 1 | 2011 | 849 | 0.060 |
Why?
|
| Spectinomycin | 1 | 1984 | 9 | 0.060 |
Why?
|
| Endophthalmitis | 2 | 1999 | 262 | 0.060 |
Why?
|
| Norepinephrine | 3 | 1978 | 909 | 0.060 |
Why?
|
| Anorexia Nervosa | 2 | 2004 | 1286 | 0.060 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1994 | 1520 | 0.060 |
Why?
|
| Empirical Research | 1 | 2005 | 120 | 0.060 |
Why?
|
| Fluorescein Angiography | 2 | 1999 | 940 | 0.060 |
Why?
|
| Disease Management | 1 | 2015 | 2460 | 0.060 |
Why?
|
| Sierra Leone | 2 | 2015 | 166 | 0.060 |
Why?
|
| Kidney Neoplasms | 2 | 1998 | 4262 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 2 | 2003 | 3616 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2002 | 4751 | 0.060 |
Why?
|
| California | 3 | 1999 | 1402 | 0.060 |
Why?
|
| Heart | 3 | 1994 | 4464 | 0.060 |
Why?
|
| Structure-Activity Relationship | 4 | 2000 | 3130 | 0.060 |
Why?
|
| Hydrogen Peroxide | 1 | 1988 | 730 | 0.060 |
Why?
|
| Ovarian Follicle | 4 | 1986 | 248 | 0.060 |
Why?
|
| Reference Values | 4 | 2009 | 4982 | 0.060 |
Why?
|
| Birds | 1 | 1984 | 163 | 0.060 |
Why?
|
| Hypothalamo-Hypophyseal System | 4 | 1994 | 703 | 0.060 |
Why?
|
| Stereotyping | 1 | 1985 | 241 | 0.060 |
Why?
|
| Castration | 3 | 1979 | 159 | 0.060 |
Why?
|
| Preoptic Area | 1 | 1984 | 146 | 0.060 |
Why?
|
| Suicide, Attempted | 2 | 2022 | 1218 | 0.060 |
Why?
|
| Visual Fields | 1 | 1990 | 1047 | 0.060 |
Why?
|
| Hydrogen | 1 | 1984 | 164 | 0.060 |
Why?
|
| Peroxides | 2 | 1998 | 74 | 0.060 |
Why?
|
| Pregnancy Complications | 3 | 1989 | 2861 | 0.060 |
Why?
|
| Subcellular Fractions | 4 | 1998 | 547 | 0.060 |
Why?
|
| Intelligence | 3 | 1978 | 920 | 0.060 |
Why?
|
| Corticosterone | 1 | 1984 | 310 | 0.060 |
Why?
|
| Kidney Tubules | 1 | 1985 | 488 | 0.060 |
Why?
|
| Hydroxysteroid Dehydrogenases | 5 | 1975 | 29 | 0.060 |
Why?
|
| Propiophenones | 2 | 1982 | 30 | 0.060 |
Why?
|
| Vulvovaginitis | 1 | 2003 | 16 | 0.060 |
Why?
|
| Program Evaluation | 2 | 2005 | 2488 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 1998 | 5857 | 0.060 |
Why?
|
| Maternal-Fetal Exchange | 2 | 1990 | 456 | 0.060 |
Why?
|
| Observation | 1 | 2005 | 312 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2000 | 9647 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 6 | 1992 | 2556 | 0.060 |
Why?
|
| Drug Resistance, Fungal | 1 | 2003 | 51 | 0.060 |
Why?
|
| Patient Care Planning | 1 | 2008 | 921 | 0.050 |
Why?
|
| Androstenedione | 5 | 1979 | 131 | 0.050 |
Why?
|
| Adrenal Glands | 4 | 1989 | 546 | 0.050 |
Why?
|
| Pattern Recognition, Visual | 2 | 1999 | 824 | 0.050 |
Why?
|
| Pregnancy | 22 | 2003 | 29144 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 13988 | 0.050 |
Why?
|
| Demography | 2 | 2006 | 1656 | 0.050 |
Why?
|
| Fluconazole | 1 | 2003 | 146 | 0.050 |
Why?
|
| Oxygen Radioisotopes | 1 | 2002 | 76 | 0.050 |
Why?
|
| Blastocyst | 1 | 1985 | 424 | 0.050 |
Why?
|
| Therapeutic Irrigation | 1 | 2004 | 301 | 0.050 |
Why?
|
| Psychology | 2 | 2015 | 356 | 0.050 |
Why?
|
| Crohn Disease | 1 | 2015 | 2304 | 0.050 |
Why?
|
| Pharyngitis | 1 | 2004 | 215 | 0.050 |
Why?
|
| Massachusetts | 2 | 2013 | 8662 | 0.050 |
Why?
|
| Visual Acuity | 3 | 1999 | 2530 | 0.050 |
Why?
|
| Cerebrovascular Circulation | 2 | 2002 | 2732 | 0.050 |
Why?
|
| Control Groups | 1 | 2021 | 105 | 0.050 |
Why?
|
| Hospitals, University | 1 | 2003 | 570 | 0.050 |
Why?
|
| Hypothalamus, Middle | 2 | 1979 | 25 | 0.050 |
Why?
|
| Psychopathology | 2 | 2021 | 409 | 0.050 |
Why?
|
| Endometrial Hyperplasia | 1 | 2002 | 97 | 0.050 |
Why?
|
| Decision Support Techniques | 1 | 2011 | 1956 | 0.050 |
Why?
|
| trans-Golgi Network | 1 | 2000 | 33 | 0.050 |
Why?
|
| Educational Status | 1 | 2009 | 2540 | 0.050 |
Why?
|
| Time Factors | 15 | 2015 | 40077 | 0.050 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2003 | 255 | 0.050 |
Why?
|
| Epithelium | 2 | 2004 | 1679 | 0.050 |
Why?
|
| Carbon Radioisotopes | 4 | 1992 | 577 | 0.050 |
Why?
|
| Dehydration | 2 | 1993 | 233 | 0.050 |
Why?
|
| Embryonic Development | 1 | 1985 | 711 | 0.050 |
Why?
|
| Human Development | 1 | 1982 | 124 | 0.050 |
Why?
|
| Rural Population | 1 | 1991 | 2207 | 0.050 |
Why?
|
| Missouri | 1 | 2000 | 117 | 0.050 |
Why?
|
| Base Pairing | 1 | 2000 | 141 | 0.050 |
Why?
|
| Chlorides | 1 | 2003 | 667 | 0.050 |
Why?
|
| North Carolina | 2 | 1991 | 315 | 0.050 |
Why?
|
| Socialization | 1 | 2000 | 87 | 0.050 |
Why?
|
| Pandemics | 1 | 2020 | 8386 | 0.050 |
Why?
|
| Pain | 1 | 1995 | 4987 | 0.050 |
Why?
|
| Candidiasis | 1 | 2003 | 366 | 0.050 |
Why?
|
| Periodicity | 1 | 2001 | 364 | 0.050 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2001 | 235 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 2006 | 2373 | 0.040 |
Why?
|
| Forecasting | 3 | 2005 | 2951 | 0.040 |
Why?
|
| Physical Stimulation | 1 | 2001 | 525 | 0.040 |
Why?
|
| Vitamin A | 1 | 2003 | 615 | 0.040 |
Why?
|
| Cats | 1 | 2021 | 1000 | 0.040 |
Why?
|
| Candida albicans | 1 | 2003 | 394 | 0.040 |
Why?
|
| Rabbits | 5 | 1986 | 4894 | 0.040 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2000 | 464 | 0.040 |
Why?
|
| Acute Disease | 2 | 2015 | 7147 | 0.040 |
Why?
|
| Hospitalization | 4 | 2016 | 10259 | 0.040 |
Why?
|
| Epithelial Cells | 2 | 2003 | 3690 | 0.040 |
Why?
|
| Streptococcal Infections | 1 | 2004 | 638 | 0.040 |
Why?
|
| Animals, Newborn | 5 | 1989 | 2726 | 0.040 |
Why?
|
| Socioeconomic Factors | 2 | 2011 | 7785 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2003 | 2943 | 0.040 |
Why?
|
| Learning | 2 | 2002 | 1712 | 0.040 |
Why?
|
| Histological Techniques | 1 | 1999 | 198 | 0.040 |
Why?
|
| Toxoplasmosis | 1 | 1999 | 91 | 0.040 |
Why?
|
| Colonic Diseases, Functional | 1 | 1999 | 38 | 0.040 |
Why?
|
| Ketorolac | 1 | 1999 | 79 | 0.040 |
Why?
|
| Pregnancy, Animal | 1 | 1980 | 134 | 0.040 |
Why?
|
| Genitalia, Male | 1 | 1979 | 84 | 0.040 |
Why?
|
| Sulfotransferases | 1 | 2000 | 151 | 0.040 |
Why?
|
| Electrooculography | 1 | 1999 | 118 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2004 | 1536 | 0.040 |
Why?
|
| Radioisotope Dilution Technique | 4 | 1981 | 70 | 0.040 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2000 | 1375 | 0.040 |
Why?
|
| Intracellular Membranes | 1 | 1980 | 391 | 0.040 |
Why?
|
| Specimen Handling | 1 | 2004 | 694 | 0.040 |
Why?
|
| Proestrus | 1 | 1978 | 19 | 0.040 |
Why?
|
| Acetylserotonin O-Methyltransferase | 1 | 1978 | 3 | 0.040 |
Why?
|
| Radioimmunoassay | 6 | 1980 | 919 | 0.040 |
Why?
|
| Rorschach Test | 1 | 1978 | 26 | 0.040 |
Why?
|
| Rats, Wistar | 4 | 1999 | 1892 | 0.040 |
Why?
|
| Eye Infections, Parasitic | 1 | 1998 | 24 | 0.040 |
Why?
|
| Morphine | 1 | 1983 | 657 | 0.040 |
Why?
|
| Climate Change | 1 | 2024 | 418 | 0.040 |
Why?
|
| Empiricism | 1 | 1998 | 7 | 0.040 |
Why?
|
| Kidney Cortex | 1 | 1998 | 186 | 0.040 |
Why?
|
| Patient Care Team | 2 | 2010 | 2531 | 0.040 |
Why?
|
| Pressure | 1 | 2001 | 1203 | 0.040 |
Why?
|
| Ophthalmic Solutions | 1 | 1999 | 317 | 0.040 |
Why?
|
| Myeloma Proteins | 1 | 1998 | 72 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2021 | 779 | 0.040 |
Why?
|
| Guanylate Cyclase | 2 | 1995 | 201 | 0.040 |
Why?
|
| Antifungal Agents | 1 | 2003 | 729 | 0.040 |
Why?
|
| Seminiferous Tubules | 1 | 1977 | 26 | 0.040 |
Why?
|
| Deoxyribonuclease IV (Phage T4-Induced) | 1 | 1997 | 9 | 0.040 |
Why?
|
| Uveitis, Anterior | 1 | 1998 | 101 | 0.040 |
Why?
|
| 5-alpha Reductase Inhibitors | 1 | 1979 | 107 | 0.040 |
Why?
|
| Lyases | 1 | 1997 | 41 | 0.040 |
Why?
|
| Feedback | 3 | 1994 | 795 | 0.040 |
Why?
|
| Character | 1 | 1997 | 26 | 0.040 |
Why?
|
| Models, Chemical | 1 | 2000 | 626 | 0.040 |
Why?
|
| Paraproteinemias | 1 | 2000 | 246 | 0.040 |
Why?
|
| Oligonucleotides | 1 | 2000 | 572 | 0.040 |
Why?
|
| Potassium Chloride | 1 | 1977 | 237 | 0.040 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 1997 | 71 | 0.040 |
Why?
|
| Length of Stay | 1 | 1990 | 6311 | 0.040 |
Why?
|
| Pilot Projects | 3 | 2020 | 8319 | 0.040 |
Why?
|
| Orientation | 1 | 1999 | 327 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1998 | 1085 | 0.040 |
Why?
|
| Prolactin | 2 | 1978 | 669 | 0.040 |
Why?
|
| Pineal Gland | 1 | 1978 | 166 | 0.040 |
Why?
|
| 17-Ketosteroids | 2 | 1973 | 39 | 0.040 |
Why?
|
| Normal Distribution | 1 | 1997 | 280 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1997 | 286 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2020 | 35424 | 0.040 |
Why?
|
| Polysorbates | 2 | 1986 | 41 | 0.030 |
Why?
|
| Verbal Learning | 1 | 1999 | 468 | 0.030 |
Why?
|
| Adrenal Cortex | 1 | 1996 | 140 | 0.030 |
Why?
|
| Cytomegalovirus Retinitis | 1 | 1996 | 58 | 0.030 |
Why?
|
| Postmenopause | 2 | 2003 | 2460 | 0.030 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 1998 | 289 | 0.030 |
Why?
|
| Toxoplasmosis, Ocular | 1 | 1996 | 29 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2001 | 14723 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2004 | 1350 | 0.030 |
Why?
|
| Delusions | 1 | 1998 | 300 | 0.030 |
Why?
|
| Videotape Recording | 1 | 1997 | 352 | 0.030 |
Why?
|
| Cognition Disorders | 2 | 1981 | 4043 | 0.030 |
Why?
|
| Aptitude | 2 | 1991 | 45 | 0.030 |
Why?
|
| Hydroxybutyrate Dehydrogenase | 1 | 1975 | 8 | 0.030 |
Why?
|
| Psychophysiology | 2 | 1999 | 135 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2000 | 1060 | 0.030 |
Why?
|
| Ganciclovir | 1 | 1996 | 258 | 0.030 |
Why?
|
| Problem Solving | 2 | 1990 | 440 | 0.030 |
Why?
|
| Central America | 1 | 1995 | 68 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 2000 | 1586 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 1998 | 596 | 0.030 |
Why?
|
| Frontal Lobe | 1 | 2002 | 1406 | 0.030 |
Why?
|
| Social Work, Psychiatric | 1 | 2015 | 24 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 1996 | 402 | 0.030 |
Why?
|
| Nociceptors | 1 | 1999 | 432 | 0.030 |
Why?
|
| Pregnanes | 2 | 1971 | 7 | 0.030 |
Why?
|
| Cerebral Cortex | 2 | 1990 | 5709 | 0.030 |
Why?
|
| Focus Groups | 1 | 2020 | 1321 | 0.030 |
Why?
|
| Aged | 5 | 2020 | 163284 | 0.030 |
Why?
|
| X-Ray Diffraction | 2 | 1988 | 420 | 0.030 |
Why?
|
| Algorithms | 2 | 2015 | 13882 | 0.030 |
Why?
|
| Goals | 1 | 2000 | 707 | 0.030 |
Why?
|
| Methyltransferases | 1 | 1978 | 367 | 0.030 |
Why?
|
| Lysosomes | 1 | 1980 | 893 | 0.030 |
Why?
|
| Prednisolone | 1 | 1996 | 334 | 0.030 |
Why?
|
| Linear Models | 2 | 2012 | 5952 | 0.030 |
Why?
|
| Private Practice | 1 | 1995 | 154 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2000 | 1434 | 0.030 |
Why?
|
| Blindness | 1 | 1999 | 615 | 0.030 |
Why?
|
| Molecular Conformation | 2 | 1988 | 562 | 0.030 |
Why?
|
| Stimulation, Chemical | 4 | 1975 | 326 | 0.030 |
Why?
|
| Helplessness, Learned | 2 | 1985 | 28 | 0.030 |
Why?
|
| Gestational Age | 5 | 1990 | 3493 | 0.030 |
Why?
|
| Atrophy | 1 | 1999 | 1584 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1996 | 798 | 0.030 |
Why?
|
| Pentobarbital | 2 | 1973 | 155 | 0.030 |
Why?
|
| Bone Marrow Examination | 1 | 1994 | 157 | 0.030 |
Why?
|
| Dwarfism | 1 | 1975 | 146 | 0.030 |
Why?
|
| Association Learning | 1 | 1975 | 224 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 2839 | 0.030 |
Why?
|
| Androgens | 3 | 1973 | 1281 | 0.030 |
Why?
|
| Sleep Deprivation | 1 | 2020 | 832 | 0.030 |
Why?
|
| India | 1 | 2020 | 2197 | 0.030 |
Why?
|
| Pituitary Gland, Posterior | 1 | 1993 | 43 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 1983 | 2408 | 0.030 |
Why?
|
| Histocompatibility Testing | 1 | 1995 | 741 | 0.030 |
Why?
|
| Program Development | 1 | 2020 | 1316 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 3848 | 0.030 |
Why?
|
| Ovarian Cysts | 2 | 1971 | 115 | 0.030 |
Why?
|
| Eye Infections, Bacterial | 1 | 1996 | 235 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2004 | 5974 | 0.030 |
Why?
|
| Swine | 4 | 1987 | 5918 | 0.030 |
Why?
|
| Mexico | 1 | 1995 | 689 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 1998 | 7722 | 0.030 |
Why?
|
| Fadrozole | 1 | 1992 | 2 | 0.030 |
Why?
|
| Infant | 6 | 2001 | 35134 | 0.030 |
Why?
|
| Chromatography, Paper | 4 | 1974 | 77 | 0.030 |
Why?
|
| Washington | 1 | 2013 | 313 | 0.030 |
Why?
|
| Health Maintenance Organizations | 1 | 1995 | 642 | 0.030 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1993 | 151 | 0.030 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1996 | 657 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2000 | 2266 | 0.030 |
Why?
|
| Binding Sites | 2 | 2000 | 6111 | 0.030 |
Why?
|
| Water Deprivation | 1 | 1992 | 21 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 1999 | 2026 | 0.030 |
Why?
|
| Protein Binding | 3 | 2000 | 9384 | 0.030 |
Why?
|
| Sample Size | 1 | 2015 | 845 | 0.030 |
Why?
|
| Spinal Puncture | 1 | 1994 | 281 | 0.030 |
Why?
|
| Relaxation Therapy | 1 | 2013 | 178 | 0.030 |
Why?
|
| Data Collection | 1 | 2021 | 3339 | 0.030 |
Why?
|
| Base Sequence | 3 | 1998 | 12797 | 0.030 |
Why?
|
| Medicine, Traditional | 1 | 1972 | 91 | 0.030 |
Why?
|
| Probability | 1 | 1997 | 2506 | 0.030 |
Why?
|
| Sinoatrial Node | 1 | 1992 | 101 | 0.030 |
Why?
|
| Sterols | 1 | 1971 | 63 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 1998 | 6171 | 0.020 |
Why?
|
| Obesity | 2 | 1993 | 12745 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 1998 | 1405 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1996 | 1213 | 0.020 |
Why?
|
| Republic of Korea | 1 | 2013 | 538 | 0.020 |
Why?
|
| Job Satisfaction | 1 | 2015 | 534 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 1996 | 2274 | 0.020 |
Why?
|
| Clofibrate | 1 | 1990 | 5 | 0.020 |
Why?
|
| Benzoflavones | 1 | 1990 | 7 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 3 | 1997 | 8300 | 0.020 |
Why?
|
| Deoxyglucose | 1 | 1992 | 337 | 0.020 |
Why?
|
| Retina | 1 | 1982 | 2616 | 0.020 |
Why?
|
| Ascorbic Acid | 3 | 1985 | 651 | 0.020 |
Why?
|
| Vomiting | 1 | 1994 | 637 | 0.020 |
Why?
|
| Contraceptives, Oral | 1 | 1973 | 564 | 0.020 |
Why?
|
| Patient Selection | 2 | 2015 | 4216 | 0.020 |
Why?
|
| Proteome | 1 | 2000 | 1798 | 0.020 |
Why?
|
| Dopamine | 3 | 1978 | 1591 | 0.020 |
Why?
|
| Cytochrome Reductases | 1 | 1990 | 9 | 0.020 |
Why?
|
| Colon | 1 | 1999 | 1772 | 0.020 |
Why?
|
| Acoustic Stimulation | 1 | 1995 | 1216 | 0.020 |
Why?
|
| Social Behavior Disorders | 1 | 1990 | 97 | 0.020 |
Why?
|
| Reproduction | 2 | 1984 | 668 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 1999 | 4777 | 0.020 |
Why?
|
| Protein Biosynthesis | 2 | 1996 | 2126 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 12244 | 0.020 |
Why?
|
| Alopecia | 1 | 1994 | 382 | 0.020 |
Why?
|
| Phenobarbital | 1 | 1990 | 193 | 0.020 |
Why?
|
| Personality Tests | 1 | 1989 | 83 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 3 | 2003 | 1877 | 0.020 |
Why?
|
| Comparative Effectiveness Research | 1 | 2015 | 681 | 0.020 |
Why?
|
| Autoantibodies | 1 | 1998 | 2036 | 0.020 |
Why?
|
| Health Behavior | 1 | 2001 | 2635 | 0.020 |
Why?
|
| Seminal Vesicles | 3 | 1981 | 101 | 0.020 |
Why?
|
| Proadifen | 2 | 1987 | 11 | 0.020 |
Why?
|
| Infertility, Female | 3 | 1971 | 788 | 0.020 |
Why?
|
| Arginine | 1 | 1993 | 944 | 0.020 |
Why?
|
| Sympathetic Nervous System | 1 | 1992 | 513 | 0.020 |
Why?
|
| Dexamethasone | 2 | 2000 | 1951 | 0.020 |
Why?
|
| Oxytocin | 1 | 1993 | 394 | 0.020 |
Why?
|
| Isoniazid | 1 | 1990 | 274 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2012 | 1005 | 0.020 |
Why?
|
| Methods | 2 | 1982 | 1129 | 0.020 |
Why?
|
| Prisons | 1 | 1990 | 161 | 0.020 |
Why?
|
| Psychiatric Department, Hospital | 1 | 1989 | 135 | 0.020 |
Why?
|
| Crystallography | 1 | 1988 | 111 | 0.020 |
Why?
|
| Graft Survival | 1 | 1999 | 3737 | 0.020 |
Why?
|
| Substrate Specificity | 3 | 1995 | 1802 | 0.020 |
Why?
|
| Naltrexone | 1 | 1990 | 307 | 0.020 |
Why?
|
| Wakefulness | 1 | 1995 | 1245 | 0.020 |
Why?
|
| Hydrogen Bonding | 1 | 1988 | 291 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2000 | 4554 | 0.020 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1989 | 393 | 0.020 |
Why?
|
| Nitriles | 1 | 1992 | 955 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2000 | 5023 | 0.020 |
Why?
|
| Organizational Case Studies | 1 | 2008 | 299 | 0.020 |
Why?
|
| Catechols | 1 | 1987 | 61 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 1996 | 1400 | 0.020 |
Why?
|
| Hydrocarbons, Fluorinated | 1 | 1986 | 39 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2013 | 1011 | 0.020 |
Why?
|
| Quinones | 1 | 1986 | 76 | 0.020 |
Why?
|
| Bacteria, Anaerobic | 1 | 1986 | 68 | 0.020 |
Why?
|
| Theca Cells | 1 | 1986 | 15 | 0.020 |
Why?
|
| Benzene Derivatives | 1 | 1986 | 54 | 0.020 |
Why?
|
| Isoelectric Focusing | 1 | 1986 | 181 | 0.020 |
Why?
|
| Medical Records | 1 | 2012 | 1413 | 0.020 |
Why?
|
| Jamaica | 3 | 1992 | 51 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2002 | 6670 | 0.020 |
Why?
|
| DNA | 1 | 2000 | 7294 | 0.020 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1986 | 306 | 0.020 |
Why?
|
| Stomach Ulcer | 2 | 1957 | 125 | 0.020 |
Why?
|
| Discrimination Learning | 2 | 1999 | 280 | 0.020 |
Why?
|
| Ovariectomy | 1 | 1989 | 661 | 0.020 |
Why?
|
| Sodium Azide | 2 | 1995 | 24 | 0.020 |
Why?
|
| Hostility | 1 | 2007 | 189 | 0.020 |
Why?
|
| Uterus | 2 | 1982 | 711 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 1856 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 1994 | 1826 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2003 | 53291 | 0.020 |
Why?
|
| Colitis, Ulcerative | 1 | 1998 | 1911 | 0.020 |
Why?
|
| Imidazoles | 1 | 1992 | 1206 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1996 | 1790 | 0.020 |
Why?
|
| Catecholamines | 1 | 1987 | 387 | 0.020 |
Why?
|
| Incidence | 2 | 1995 | 20950 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2003 | 11486 | 0.020 |
Why?
|
| Azides | 2 | 1995 | 116 | 0.020 |
Why?
|
| Hypophysectomy | 2 | 1977 | 113 | 0.020 |
Why?
|
| Child Welfare | 1 | 2010 | 523 | 0.020 |
Why?
|
| Counseling | 1 | 2013 | 1523 | 0.020 |
Why?
|
| Plasma Cells | 2 | 2000 | 591 | 0.020 |
Why?
|
| Amygdala | 3 | 1982 | 1315 | 0.020 |
Why?
|
| Models, Molecular | 2 | 1988 | 5451 | 0.020 |
Why?
|
| Ouabain | 1 | 1985 | 264 | 0.020 |
Why?
|
| Social Support | 1 | 2015 | 2118 | 0.020 |
Why?
|
| Regression Analysis | 2 | 2003 | 6459 | 0.020 |
Why?
|
| Apoptosis | 2 | 2000 | 9726 | 0.020 |
Why?
|
| Steroids | 1 | 1970 | 930 | 0.020 |
Why?
|
| Ovarian Diseases | 2 | 1966 | 139 | 0.020 |
Why?
|
| Trypsin | 1 | 1986 | 511 | 0.020 |
Why?
|
| Peptic Ulcer | 2 | 1957 | 223 | 0.020 |
Why?
|
| Organ Size | 4 | 1981 | 2251 | 0.020 |
Why?
|
| Urban Health | 1 | 1987 | 547 | 0.020 |
Why?
|
| Receptors, Cell Surface | 2 | 1989 | 2866 | 0.020 |
Why?
|
| Methylation | 3 | 1990 | 1106 | 0.020 |
Why?
|
| Random Allocation | 1 | 1989 | 2428 | 0.010 |
Why?
|
| Body Mass Index | 2 | 1993 | 12720 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 1993 | 2132 | 0.010 |
Why?
|
| Recurrence | 3 | 2003 | 8340 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 1996 | 2987 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1996 | 2214 | 0.010 |
Why?
|
| Alpha Rhythm | 1 | 2004 | 120 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2000 | 7882 | 0.010 |
Why?
|
| Mice | 3 | 2000 | 81202 | 0.010 |
Why?
|
| Multiple Myeloma | 2 | 2000 | 5181 | 0.010 |
Why?
|
| Communication | 1 | 1997 | 3750 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 1988 | 1150 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3508 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 1995 | 2647 | 0.010 |
Why?
|
| Philadelphia | 1 | 2003 | 267 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 1998 | 5173 | 0.010 |
Why?
|
| Butanols | 1 | 2002 | 19 | 0.010 |
Why?
|
| Pregnenolone | 3 | 1971 | 26 | 0.010 |
Why?
|
| Theta Rhythm | 1 | 2004 | 207 | 0.010 |
Why?
|
| Psychiatry | 1 | 2015 | 1695 | 0.010 |
Why?
|
| Receptors, Opioid | 1 | 1983 | 155 | 0.010 |
Why?
|
| Neuroblastoma | 2 | 1982 | 1226 | 0.010 |
Why?
|
| Neisseria gonorrhoeae | 1 | 1984 | 238 | 0.010 |
Why?
|
| Cattle | 2 | 1978 | 3922 | 0.010 |
Why?
|
| Semantics | 1 | 1985 | 585 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1984 | 1828 | 0.010 |
Why?
|
| Receptors, Estrogen | 2 | 1996 | 2190 | 0.010 |
Why?
|
| Sertoli Cells | 1 | 1981 | 49 | 0.010 |
Why?
|
| Social Behavior | 2 | 1999 | 1127 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2008 | 2539 | 0.010 |
Why?
|
| Blotting, Western | 2 | 2000 | 5181 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 3 | 1971 | 223 | 0.010 |
Why?
|
| Cysts | 2 | 1966 | 678 | 0.010 |
Why?
|
| Carcinogens | 2 | 1996 | 466 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2004 | 1308 | 0.010 |
Why?
|
| Pituitary-Adrenal System | 2 | 1994 | 553 | 0.010 |
Why?
|
| Veins | 4 | 1973 | 770 | 0.010 |
Why?
|
| Mammary Glands, Animal | 1 | 1982 | 276 | 0.010 |
Why?
|
| Detergents | 1 | 2000 | 230 | 0.010 |
Why?
|
| Hospitals, Psychiatric | 2 | 1990 | 332 | 0.010 |
Why?
|
| Cell-Free System | 1 | 2000 | 344 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1996 | 4253 | 0.010 |
Why?
|
| Densitometry | 1 | 1980 | 156 | 0.010 |
Why?
|
| Lung | 1 | 1979 | 9857 | 0.010 |
Why?
|
| Limbic System | 1 | 1983 | 426 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1984 | 982 | 0.010 |
Why?
|
| Choroiditis | 1 | 1999 | 12 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 1993 | 4464 | 0.010 |
Why?
|
| Saliva | 2 | 1994 | 809 | 0.010 |
Why?
|
| Aminopeptidases | 1 | 1980 | 88 | 0.010 |
Why?
|
| Retinitis | 1 | 1999 | 35 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 1998 | 3873 | 0.010 |
Why?
|
| Bacterial Infections | 2 | 1986 | 1401 | 0.010 |
Why?
|
| Health Surveys | 1 | 2010 | 4036 | 0.010 |
Why?
|
| Aminopyrine N-Demethylase | 1 | 1979 | 1 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2000 | 285 | 0.010 |
Why?
|
| Membranes | 1 | 1979 | 173 | 0.010 |
Why?
|
| Citric Acid | 1 | 1999 | 126 | 0.010 |
Why?
|
| Choroid Diseases | 1 | 1999 | 66 | 0.010 |
Why?
|
| Disorders of Sex Development | 1 | 1980 | 122 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2000 | 295 | 0.010 |
Why?
|
| Sleep | 1 | 1995 | 4623 | 0.010 |
Why?
|
| Tissue Preservation | 1 | 1999 | 182 | 0.010 |
Why?
|
| Ectoparasitic Infestations | 1 | 1998 | 12 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 1998 | 69 | 0.010 |
Why?
|
| Placenta | 1 | 1988 | 1699 | 0.010 |
Why?
|
| Melphalan | 1 | 2000 | 431 | 0.010 |
Why?
|
| Carbon Monoxide | 2 | 1979 | 531 | 0.010 |
Why?
|
| Haplorhini | 1 | 1979 | 552 | 0.010 |
Why?
|
| Species Specificity | 1 | 1983 | 2478 | 0.010 |
Why?
|
| Cell Line | 3 | 2000 | 16000 | 0.010 |
Why?
|
| Self Mutilation | 1 | 1998 | 58 | 0.010 |
Why?
|
| Logistic Models | 1 | 2013 | 13409 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 1978 | 313 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2000 | 937 | 0.010 |
Why?
|
| Acetates | 1 | 1999 | 311 | 0.010 |
Why?
|
| Vincristine | 1 | 2000 | 1039 | 0.010 |
Why?
|
| Permeability | 1 | 1980 | 738 | 0.010 |
Why?
|
| Leukemia, Plasma Cell | 1 | 1998 | 48 | 0.010 |
Why?
|
| Oxides | 1 | 1999 | 405 | 0.010 |
Why?
|
| Survival Analysis | 1 | 1990 | 10252 | 0.010 |
Why?
|
| Chromatography, Gas | 2 | 1994 | 156 | 0.010 |
Why?
|
| Health Policy | 1 | 2010 | 2661 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 1999 | 57776 | 0.010 |
Why?
|
| Biological Assay | 2 | 1979 | 652 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1991 | 6442 | 0.010 |
Why?
|
| Caudate Nucleus | 1 | 1978 | 393 | 0.010 |
Why?
|
| Drug Resistance, Multiple | 1 | 1998 | 252 | 0.010 |
Why?
|
| Succinate Dehydrogenase | 2 | 1968 | 146 | 0.010 |
Why?
|
| Dimethylnitrosamine | 1 | 1996 | 16 | 0.010 |
Why?
|
| Mycobacterium avium Complex | 1 | 1996 | 60 | 0.010 |
Why?
|
| Neurotic Disorders | 1 | 1956 | 79 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2000 | 1547 | 0.010 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1996 | 104 | 0.010 |
Why?
|
| Ethynodiol Diacetate | 2 | 1973 | 5 | 0.010 |
Why?
|
| Spermatogenesis | 1 | 1977 | 262 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 1968 | 424 | 0.010 |
Why?
|
| Sulfadiazine | 1 | 1996 | 18 | 0.010 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 1996 | 76 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 1998 | 411 | 0.010 |
Why?
|
| Gonadotropins, Pituitary | 2 | 1966 | 73 | 0.010 |
Why?
|
| Medroxyprogesterone | 2 | 1973 | 37 | 0.010 |
Why?
|
| Stanford-Binet Test | 1 | 1975 | 3 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1998 | 1095 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2000 | 2256 | 0.010 |
Why?
|
| Chorioretinitis | 1 | 1996 | 43 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 1999 | 798 | 0.010 |
Why?
|
| RNA, Antisense | 1 | 1996 | 138 | 0.010 |
Why?
|
| Myocardium | 1 | 1989 | 4772 | 0.010 |
Why?
|
| Pyrimethamine | 1 | 1996 | 97 | 0.010 |
Why?
|
| Orotic Acid | 1 | 1975 | 23 | 0.010 |
Why?
|
| Prednisone | 1 | 2000 | 1574 | 0.010 |
Why?
|
| Vasculitis | 1 | 1999 | 519 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1975 | 191 | 0.010 |
Why?
|
| Rodent Diseases | 1 | 1975 | 57 | 0.010 |
Why?
|
| Androstenediols | 1 | 1974 | 1 | 0.010 |
Why?
|
| Steroid 16-alpha-Hydroxylase | 1 | 1994 | 12 | 0.010 |
Why?
|
| Boston | 1 | 2008 | 9312 | 0.010 |
Why?
|
| DNA Probes | 1 | 1996 | 560 | 0.010 |
Why?
|
| Necrosis | 1 | 1999 | 1643 | 0.010 |
Why?
|
| Antidotes | 1 | 1996 | 138 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1977 | 621 | 0.010 |
Why?
|
| Eye Injuries | 1 | 1998 | 245 | 0.010 |
Why?
|
| Pain Threshold | 1 | 1999 | 584 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 4320 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2003 | 40558 | 0.010 |
Why?
|
| Toxoplasma | 1 | 1996 | 150 | 0.010 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1981 | 1115 | 0.010 |
Why?
|
| Antibodies, Protozoan | 1 | 1996 | 253 | 0.010 |
Why?
|
| Vitreous Body | 1 | 1996 | 389 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1996 | 1581 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1974 | 419 | 0.010 |
Why?
|
| Prostate | 2 | 1981 | 1775 | 0.010 |
Why?
|
| Racemases and Epimerases | 1 | 1975 | 113 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 2 | 1996 | 7182 | 0.010 |
Why?
|
| Lead | 1 | 1999 | 852 | 0.010 |
Why?
|
| Mestranol | 1 | 1973 | 9 | 0.010 |
Why?
|
| Leucovorin | 1 | 1996 | 628 | 0.010 |
Why?
|
| Retinal Vessels | 1 | 1999 | 772 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1977 | 10943 | 0.010 |
Why?
|
| Cicatrix | 1 | 1999 | 764 | 0.010 |
Why?
|
| Catheters, Indwelling | 1 | 1996 | 426 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2000 | 2234 | 0.010 |
Why?
|
| Supraoptic Nucleus | 1 | 1993 | 28 | 0.010 |
Why?
|
| Iproniazid | 1 | 1973 | 8 | 0.010 |
Why?
|
| Nialamide | 1 | 1973 | 6 | 0.010 |
Why?
|
| omega-N-Methylarginine | 1 | 1993 | 111 | 0.010 |
Why?
|
| Reserpine | 1 | 1973 | 66 | 0.010 |
Why?
|
| Retinal Diseases | 1 | 1999 | 684 | 0.010 |
Why?
|
| Epididymis | 1 | 1975 | 227 | 0.010 |
Why?
|
| Dihydroxyphenylalanine | 1 | 1973 | 76 | 0.010 |
Why?
|
| Perfusion | 1 | 1977 | 1360 | 0.010 |
Why?
|
| Sexual Behavior | 1 | 1983 | 2055 | 0.010 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 1993 | 113 | 0.010 |
Why?
|
| Superstitions | 1 | 1972 | 3 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1993 | 254 | 0.010 |
Why?
|
| Self-Injurious Behavior | 1 | 1998 | 464 | 0.010 |
Why?
|
| Serotonin | 1 | 1977 | 1017 | 0.010 |
Why?
|
| Africa, Eastern | 1 | 1972 | 71 | 0.010 |
Why?
|
| Ceremonial Behavior | 1 | 1972 | 18 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1996 | 913 | 0.010 |
Why?
|
| Cell Division | 1 | 2000 | 4569 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1977 | 2008 | 0.010 |
Why?
|
| Proteins | 2 | 1985 | 6100 | 0.010 |
Why?
|
| Dehydroepiandrosterone | 2 | 1971 | 252 | 0.010 |
Why?
|
| Menstruation | 2 | 1971 | 302 | 0.010 |
Why?
|
| Philosophy, Medical | 1 | 1972 | 79 | 0.010 |
Why?
|
| Premenopause | 1 | 1996 | 1033 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1996 | 1950 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2000 | 3773 | 0.010 |
Why?
|
| Carcinoma, Lobular | 1 | 1996 | 484 | 0.010 |
Why?
|
| DNA Primers | 1 | 1996 | 2891 | 0.010 |
Why?
|
| Punctures | 1 | 1973 | 374 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1995 | 20130 | 0.010 |
Why?
|
| Receptors, Progesterone | 1 | 1996 | 1098 | 0.010 |
Why?
|
| Dydrogesterone | 1 | 1971 | 1 | 0.010 |
Why?
|
| Adrenalectomy | 1 | 1973 | 341 | 0.010 |
Why?
|
| Vasopressins | 1 | 1993 | 370 | 0.010 |
Why?
|
| Melatonin | 1 | 1977 | 721 | 0.010 |
Why?
|
| beta-Naphthoflavone | 1 | 1990 | 5 | 0.010 |
Why?
|
| Hydroxyprogesterones | 1 | 1971 | 25 | 0.010 |
Why?
|
| Pregnanediol | 1 | 1970 | 18 | 0.010 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 1973 | 392 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 1994 | 13695 | 0.010 |
Why?
|
| Corpus Luteum | 1 | 1970 | 86 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1973 | 688 | 0.010 |
Why?
|
| Phytotherapy | 1 | 1972 | 298 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 1998 | 2513 | 0.010 |
Why?
|
| Free Radicals | 1 | 1990 | 237 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2000 | 2948 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1998 | 6314 | 0.010 |
Why?
|
| Fallopian Tubes | 1 | 1970 | 182 | 0.010 |
Why?
|
| Buffers | 1 | 1989 | 147 | 0.010 |
Why?
|
| Radiochemistry | 1 | 1989 | 55 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2000 | 3771 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2000 | 6896 | 0.010 |
Why?
|
| Sulfates | 1 | 1970 | 390 | 0.010 |
Why?
|
| Bacteremia | 1 | 1996 | 963 | 0.010 |
Why?
|
| Epinephrine | 1 | 1973 | 792 | 0.010 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 1989 | 54 | 0.010 |
Why?
|
| Superoxides | 1 | 1990 | 387 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1984 | 8551 | 0.010 |
Why?
|
| Catheterization | 1 | 1974 | 1470 | 0.010 |
Why?
|
| Up-Regulation | 1 | 1998 | 4222 | 0.010 |
Why?
|
| Uganda | 1 | 1973 | 1237 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2000 | 11525 | 0.000 |
Why?
|
| Body Weight | 2 | 1981 | 4671 | 0.000 |
Why?
|
| Anti-Infective Agents | 1 | 1996 | 974 | 0.000 |
Why?
|
| Biopsy | 1 | 2000 | 6755 | 0.000 |
Why?
|
| Staphylococcus aureus | 1 | 1996 | 1453 | 0.000 |
Why?
|
| Autoradiography | 1 | 1989 | 745 | 0.000 |
Why?
|
| Opioid-Related Disorders | 1 | 1983 | 2064 | 0.000 |
Why?
|
| Regional Blood Flow | 1 | 1971 | 1525 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 2001 | 12025 | 0.000 |
Why?
|
| Fetal Heart | 1 | 1989 | 276 | 0.000 |
Why?
|
| Disease | 1 | 1972 | 680 | 0.000 |
Why?
|
| Bacillus | 1 | 1986 | 77 | 0.000 |
Why?
|
| Mixed Function Oxygenases | 1 | 1987 | 272 | 0.000 |
Why?
|
| Ileum | 1 | 1989 | 565 | 0.000 |
Why?
|
| Endocrine Glands | 1 | 1966 | 103 | 0.000 |
Why?
|
| Health Education | 1 | 1972 | 1056 | 0.000 |
Why?
|
| Litter Size | 1 | 1984 | 54 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2002 | 8949 | 0.000 |
Why?
|
| Rats, Inbred WKY | 1 | 1984 | 158 | 0.000 |
Why?
|
| Hypertension | 1 | 1984 | 8479 | 0.000 |
Why?
|
| Medicine | 1 | 1972 | 946 | 0.000 |
Why?
|
| Fibroblasts | 1 | 1973 | 4162 | 0.000 |
Why?
|
| Sexual Maturation | 1 | 1984 | 265 | 0.000 |
Why?
|
| Language | 1 | 1972 | 1471 | 0.000 |
Why?
|
| Fetal Death | 1 | 1984 | 448 | 0.000 |
Why?
|
| Circadian Rhythm | 1 | 1994 | 2624 | 0.000 |
Why?
|
| Lipids | 1 | 1973 | 3307 | 0.000 |
Why?
|
| Antibodies | 1 | 1990 | 2460 | 0.000 |
Why?
|
| Contraception | 1 | 1966 | 359 | 0.000 |
Why?
|
| Androgen-Binding Protein | 1 | 1981 | 10 | 0.000 |
Why?
|
| Antioxidants | 1 | 1989 | 1659 | 0.000 |
Why?
|
| Risk Assessment | 1 | 2003 | 23336 | 0.000 |
Why?
|
| Neoplasms | 1 | 1990 | 21693 | 0.000 |
Why?
|
| Aging | 1 | 1980 | 8663 | 0.000 |
Why?
|
| Hexobarbital | 1 | 1979 | 4 | 0.000 |
Why?
|
| Benzopyrenes | 1 | 1979 | 5 | 0.000 |
Why?
|
| Meperidine | 1 | 1979 | 38 | 0.000 |
Why?
|
| Pyrogallol | 1 | 1978 | 8 | 0.000 |
Why?
|
| Chorionic Gonadotropin | 1 | 1981 | 476 | 0.000 |
Why?
|
| Pseudopregnancy | 1 | 1978 | 11 | 0.000 |
Why?
|
| Rete Testis | 1 | 1977 | 9 | 0.000 |
Why?
|
| Decidua | 1 | 1978 | 86 | 0.000 |
Why?
|
| Body Fluids | 1 | 1977 | 319 | 0.000 |
Why?
|
| Aniline Compounds | 1 | 1979 | 986 | 0.000 |
Why?
|
| Carbon Isotopes | 1 | 1971 | 467 | 0.000 |
Why?
|
| Chlormadinone Acetate | 1 | 1969 | 2 | 0.000 |
Why?
|
| Radiation Injuries, Experimental | 1 | 1968 | 91 | 0.000 |
Why?
|
| Chemosterilants | 1 | 1966 | 1 | 0.000 |
Why?
|
| Tetrazolium Salts | 1 | 1966 | 96 | 0.000 |
Why?
|
| Blood Glucose | 1 | 1981 | 6254 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1984 | 18034 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1973 | 77459 | 0.000 |
Why?
|
| Light | 1 | 1968 | 1374 | 0.000 |
Why?
|